Mark S. Roh

Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

Mark S. Roh, Linda H. Colangelo, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2009 · 942 citations · Full text

Medicine, Oncology, Surgery +17

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

Michael J. O’Connell, Linda H. Colangelo, Robert W. Beart et al. · Journal of Clinical Oncology · 2014 · 441 citations · Full text

Medicine, Oncology, Surgery +16

Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

Mark S. Talamonti, Mark S. Roh, S. Curley et al. · Journal of Clinical Investigation · 1993 · 397 citations · Full text

Medicine, Molecular Biology, Oncology +17

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies

A. Scott Pearson, Francesco Izzo, R.Y.Declan Fleming et al. · The American Journal of Surgery · 1999 · 370 citations

Medicine, Oncology, Surgery +14

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · JNCI Journal of the National Cancer Institute · 2015 · 328 citations · Full text

Medicine, Oncology, Radiation Oncology +17